Venturepharm Laboratories Ltd. provided earnings guidance for the full year ended December 31, 2011. The board of directors announced that based on information currently available, the company and its subsidiaries is expected to record a loss for the year. Such loss was primarily attributable to the loss of investments in certain financial assets.